Suppression of Bcl-xL deamidation in human hepatocellular carcinomas

Cancer Research

Volumn 63, Issue 12, 2003, Pages 3054-3057

  Takehara, Tetsuo ^a   Takahashi, Hiroshi ^b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ASPARAGINE; PHOSPHATASE; PROTEIN BCL 2; PROTEIN BCL XL; RECOMBINANT PROTEIN;

APOPTOSIS; ARTICLE; CELL STRAIN HEPG2; CELL SURVIVAL; CONTROLLED STUDY; DEAMINATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LIVER CELL CARCINOMA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; SITE DIRECTED MUTAGENESIS; WESTERN BLOTTING;

AMIDES; AMINO ACID SUBSTITUTION; APOPTOSIS; BCL-X PROTEIN; CARCINOMA, HEPATOCELLULAR; CELL SURVIVAL; CODON; CRYOPRESERVATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HEPATOCYTES; HUMANS; HYDROGEN-ION CONCENTRATION; ISOASPARTIC ACID; LIVER NEOPLASMS; MUTAGENESIS, SITE-DIRECTED; NEOPLASM PROTEINS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-BCL-2; RECOMBINANT FUSION PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0038746592     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Adams, J. M., and Cory, S. The Bcl-2 protein family: abilers of cell survival, Science (Wash. DC), 281: 1322-1326, 1998.
2. Gross, A., McDonnell, J. M., and Korsmeyer, S. J. BCL-2 family members and the mitochondria in apoptosis. Genes Dev., 13: 1899-1911, 1999.
3. Takehara, T., Liu, X., Fujimoto, J., Friedman, S. L., and Takahashi, T. Expression and role of Bcl-χL in human hepatocellular carcinomas. Hepatology, 34: 55-61, 2001.
4. Deverman, B. E., Cook, B. L., Manson, S. R., Niederhoff, R. A., Langer, E,. M., Rosová, I., Kutans, L. A., Fu, X., Weinberg, J. S., Heinecke, J. W., Roth, K. A., and Weintraub, S. J. Bcl-xL deamidation is a critical switch in the regulation of the response to DNA damage, Cell, 111: 51-62, 2002.
5. Paisieux, A., Galvin, K., Troalen, F., Bressac, B., Marcais, C., Galun, E., Ponchel, F., Yakicier, C., Ji, J., and Ozturk, M. RetinobIastoma and p53 tumor suppressor genes in human hepatoma cell lines. FASB J., 7: 1407-1413, 1993.
6. Hu, Y., Benedict, M. A., Wu, D., Inohara, N., and Núñez, G. Bcl-XL interacts with Apaf-I and inhibits Apaf-I-dependent caspase-9 activation. Proc. Natl. Acad. Sci. USA, 95: 4386-4391, 1998.
7. Paranandi, M. V., Guzzetta, A. W., Hancock, W. S., and Aswad, D. W. Deamidation and isoaspartate formation during in vitro aging of recombinant tissue plasminogen activator, J. Biol. Chem. 269: 243-253, 1994.
8. Poruchynsky, M. S., Wang, E. E., Rudin, C. M., Blagosklonny M. V., and Fojo, T. Bcl-xL is phosphorylated in malignant eegs following microtubule disruption. Cancer Res., 58, 3331-3338, 1998.
9. Aritomi, M., Kunishima, N., Inohara, N., Ishibashi, Y., Ohta, S., and Morikawa, K. Crystal structure of rat Bcl-xL. J. Biol. Chem., 272: 27886-27892, 1997.
10. , Robinson, A. B., and Rudd, C. J. Deamidationn of glutaminyl and asparaginyl residues in peptides and proteins. Curr. Top. Cell. Regul., 8: 247-295, 1974.
11. Aswad, D. W., Paranandi, M. V., and Schuner, B. T. Isoaspartate in peptides and proteins: formation, significance, and analysis. J. Pharm. Biomed. Anal., 21: 1129-1136, 2000
12. Muchmore, S. W., Satller, M., Liang, H., Meadows, R. P., Harlan, J. E., Yoon, H. S., Neltesheim, D., Chang, B. S. Thompson. C. B., Wong, S. L., Ng, S. L., and Fesik, S. W. X-ray and NMR struture of human Bcl-xL, an inhibitor of programmed cell death. Nature (Lond.), 381: 335-341, 1996.
13. Robinson, N. E. Protein deamidation. Proc. Natl. Acad. Sci. USA, 99: 5283-5288, 2002.
14. Krajewska, M., Moss, S. F., Krajewski, S., Song, K., Holt, P. R., and Reed, J. C. Elevated expression of Bcl-xL and reduced Bak in primary colorectal adenocarcinomas. Cancer Res., 56: 2422-2427, 1996.
15. Foreman, K. E., Wrone-Smith, T., Boise, L. H., Thompson, C. B., Polverini, P. J., Simonian, P. L., Nuñez, G., and Nickoloff, B. J. Kaposi's sarcoma tumor cells preferentially express Bcl-xL. Am. J. Pathol., 149: 795-803, 1996.
16. Tu, Y., Renner, S., Xu, F., Fleishman, A., Taylor, J., Weisz, J., Vescio, R., Rettig, M., Berenson, J., Krajewski, S., Reed, J. C., and Lichtenstein, A. A BCL-X expression in multiple rayeloma: possible indicator of chemoresistance. Cancer Res., 58: 256-262, 1998.